Putman 3rd H
Psychiatr Res Clin Pract. 2024; 6(3):112-114.
PMID: 39568503
PMC: 11574440.
DOI: 10.1176/appi.prcp.20240073.
Jobnah S, Latifeh Y, Al Kabani D, Youssef L
BMC Psychiatry. 2024; 24(1):745.
PMID: 39468512
PMC: 11520900.
DOI: 10.1186/s12888-024-06203-2.
Austelle C, Seery E
Am J Psychoanal. 2024; 84(2):285-310.
PMID: 38871924
DOI: 10.1057/s11231-024-09444-y.
Cosgrove L, Patterson E, Bursztajn H
Front Med (Lausanne). 2024; 10:1320304.
PMID: 38322498
PMC: 10845136.
DOI: 10.3389/fmed.2023.1320304.
Adu M, Dias R, Agyapong B, Eboreime E, Sapara A, Lawal M
JMIR Res Protoc. 2023; 12:e46830.
PMID: 38060308
PMC: 10739251.
DOI: 10.2196/46830.
The Montreal model: an integrative biomedical-psychedelic approach to ketamine for severe treatment-resistant depression.
Garel N, Drury J, Thibault Levesque J, Goyette N, Lehmann A, Looper K
Front Psychiatry. 2023; 14:1268832.
PMID: 37795512
PMC: 10546328.
DOI: 10.3389/fpsyt.2023.1268832.
Does treatment-resistant depression need psychotherapy?.
Weissman M
World Psychiatry. 2023; 22(3):417-418.
PMID: 37713551
PMC: 10503899.
DOI: 10.1002/wps.21137.
Treatment-resistant depression: definition, prevalence, detection, management, and investigational interventions.
McIntyre R, Alsuwaidan M, Baune B, Berk M, Demyttenaere K, Goldberg J
World Psychiatry. 2023; 22(3):394-412.
PMID: 37713549
PMC: 10503923.
DOI: 10.1002/wps.21120.
Antidepressant mechanisms of ketamine: a review of actions with relevance to treatment-resistance and neuroprogression.
Lullau A, Haga E, Ronold E, Dwyer G
Front Neurosci. 2023; 17:1223145.
PMID: 37614344
PMC: 10442706.
DOI: 10.3389/fnins.2023.1223145.
Intravenous ketamine for benzodiazepine deprescription and withdrawal management in treatment-resistant depression: a preliminary report.
Garel N, Greenway K, Dinh-Williams L, Thibault-Levesque J, Jutras-Aswad D, Turecki G
Neuropsychopharmacology. 2023; 48(12):1769-1777.
PMID: 37532888
PMC: 10579413.
DOI: 10.1038/s41386-023-01689-y.
Association of Treatment-Resistant Depression With Patient Outcomes and Health Care Resource Utilization in a Population-Wide Study.
Lundberg J, Cars T, Loov S, Soderling J, Sundstrom J, Tiihonen J
JAMA Psychiatry. 2022; 80(2):167-175.
PMID: 36515938
PMC: 9856735.
DOI: 10.1001/jamapsychiatry.2022.3860.
The Effectiveness of an Intensive Inpatient Psychotherapy Program for Chronic Depression: A naturalistic comparison with wait list.
Eielsen M, Ulvenes P, Rossberg J, Hostmaelingen A, Soma C, Wampold B
BMC Psychiatry. 2022; 22(1):745.
PMID: 36451114
PMC: 9710086.
DOI: 10.1186/s12888-022-04381-5.
Investigating post-traumatic stress disorder (PTSD) and complex PTSD among people with self-reported depressive symptoms.
Fung H, Chien W, Lam S, Ross C
Front Psychiatry. 2022; 13:953001.
PMID: 36339839
PMC: 9627202.
DOI: 10.3389/fpsyt.2022.953001.
